Sign inJoin waitlistJoin the waitlist

Jose Lutzky

Director, Cutaneous Oncology, Medical Oncology · University of Miami/Jackson Health System

Credentials: · · · · ·

History

Clinical Trials Coordination Unit · University of Miami/Jackson Health System
Present
University of Miami/Jackson Health System
Present

Hematology and Medical Oncology
New York Presbyterian Hospital
1983–1986
Mount Sinai Medical Center
1980–1983
Faculdade de Medicina da Universidade Federal do Rio Grande do Sul
1976–1980

Research

Improved survival with ipilimumab in patients with metastatic melanoma
New England Journal of Medicine · 2010 · 12,191 citations
Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
The Lancet Oncology · 2010 · 979 citations
KIT as a therapeutic target in metastatic melanoma
JAMA · 2011 · 665 citations

JW
Jeffrey Weber
9 papers
KB
Kapil Bhalla
9 papers
RC
Richard Carvajal
8 papers
Brendan Curti
7 papers
Leonel Aya
7 papers
Omid Hamid
7 papers
RG
Rene Gonzalez-Cotarelo
7 papers
SO
Steven O'Day
7 papers
Thomas Gajewski
7 papers
Anna Pavlick
6 papers
KL
Karl Lewis
6 papers
David Lawson
5 papers

Clinical trials

Adjuvant Quisinostat in High-Risk Uveal Melanoma
Principal investigator · Recruiting · Phase 2
University of Miami
2025–2030
Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma
Principal investigator · Completed · Phase 2
Jose Lutzky, MD
2020–2026
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments
Principal investigator · Active not recruiting
OncoHost Ltd.
2019–2029
CAVATAK® and Ipilimumab in Uveal Melanoma Metastatic to the Liver (VLA-024 CLEVER)
Principal investigator · Completed · Phase 1
Viralytics
2018–2019